165 related articles for article (PubMed ID: 22194983)
1. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.
Yuan LQ; Zhu JH; Wang HW; Liang QH; Xie H; Wu XP; Zhou H; Cui RR; Sheng ZF; Zhou HD; Zhu X; Liu GY; Liu YS; Liao EY
PLoS One; 2011; 6(12):e29037. PubMed ID: 22194983
[TBL] [Abstract][Full Text] [Related]
2. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression.
Liu GY; Liang QH; Cui RR; Liu Y; Wu SS; Shan PF; Yuan LQ; Liao EY
Endocrinology; 2014 Feb; 155(2):558-67. PubMed ID: 24248461
[TBL] [Abstract][Full Text] [Related]
3. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells.
Shan PF; Lu Y; Cui RR; Jiang Y; Yuan LQ; Liao EY
PLoS One; 2011 Mar; 6(3):e17938. PubMed ID: 21437254
[TBL] [Abstract][Full Text] [Related]
4. Puerarin attenuates calcification of vascular smooth muscle cells.
Lu Q; Xiang DX; Yuan HY; Xiao Y; Yuan LQ; Li HB
Am J Chin Med; 2014; 42(2):337-47. PubMed ID: 24707866
[TBL] [Abstract][Full Text] [Related]
5. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.
Zhan JK; Tan P; Wang YJ; Wang Y; He JY; Tang ZY; Huang W; Liu YS
Cardiovasc Diabetol; 2014 Nov; 13():153. PubMed ID: 25407893
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway.
Liang QH; Jiang Y; Zhu X; Cui RR; Liu GY; Liu Y; Wu SS; Liao XB; Xie H; Zhou HD; Wu XP; Yuan LQ; Liao EY
PLoS One; 2012; 7(4):e33126. PubMed ID: 22514603
[TBL] [Abstract][Full Text] [Related]
7. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway.
Duan XY; Xie PL; Ma YL; Tang SY
Amino Acids; 2011 Nov; 41(5):1223-31. PubMed ID: 21082206
[TBL] [Abstract][Full Text] [Related]
8. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
Xie H; Xie PL; Wu XP; Chen SM; Zhou HD; Yuan LQ; Sheng ZF; Tang SY; Luo XH; Liao EY
Cardiovasc Res; 2011 Nov; 92(2):296-306. PubMed ID: 21750093
[TBL] [Abstract][Full Text] [Related]
9. Vinpocetine Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells.
Ma YY; Sun L; Chen XJ; Wang N; Yi PF; Song M; Zhang B; Wang YZ; Liang QH
PLoS One; 2016; 11(9):e0162295. PubMed ID: 27589055
[TBL] [Abstract][Full Text] [Related]
10. Globular adiponectin inhibits osteoblastic differentiation of vascular smooth muscle cells through the PI3K/AKT and Wnt/β-catenin pathway.
Zhou Y; Wei LL; Zhang RP; Han CW; Cao Y
J Mol Histol; 2021 Oct; 52(5):1067-1080. PubMed ID: 34398360
[TBL] [Abstract][Full Text] [Related]
11. Hepatoma-derived growth factor enhances osteoblastic transformation of rat aortic vascular smooth muscle cells in vitro.
Cheng CI; Chang HR; Tai MH; Chou MH; Chen GT; Chen PH; Kao YH
Life Sci; 2020 Sep; 256():117964. PubMed ID: 32534036
[TBL] [Abstract][Full Text] [Related]
12. Apelin attenuates the osteoblastic differentiation of aortic valve interstitial cells via the ERK and PI3-K/Akt pathways.
Yuan ZS; Zhou YZ; Liao XB; Luo JW; Shen KJ; Hu YR; Gu L; Li JM; Tan CM; Chen HM; Zhou XM
Amino Acids; 2015 Dec; 47(12):2475-82. PubMed ID: 26142632
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification.
Tang Y; Xu Q; Peng H; Liu Z; Yang T; Yu Z; Cheng G; Li X; Zhang G; Shi R
Atherosclerosis; 2015 Dec; 243(2):357-63. PubMed ID: 26520887
[TBL] [Abstract][Full Text] [Related]
14. Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation.
Liu H; Lu Q; Huang K
J Cell Biochem; 2010 Dec; 111(6):1556-64. PubMed ID: 21053344
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells via ERK pathway.
Ding HT; Wang CG; Zhang TL; Wang K
J Cell Biochem; 2006 Dec; 99(5):1343-52. PubMed ID: 16795048
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway.
Wang YD; Tao MF; Wang L; Cheng WW; Wan XP
Horm Metab Res; 2012 Jun; 44(7):494-500. PubMed ID: 22556124
[TBL] [Abstract][Full Text] [Related]
17. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
[TBL] [Abstract][Full Text] [Related]
18. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
19. PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification.
Tseng W; Graham LS; Geng Y; Reddy A; Lu J; Effros RB; Demer L; Tintut Y
J Biol Chem; 2010 Sep; 285(39):29925-31. PubMed ID: 20663885
[TBL] [Abstract][Full Text] [Related]
20. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways.
Tang SY; Xie H; Yuan LQ; Luo XH; Huang J; Cui RR; Zhou HD; Wu XP; Liao EY
Peptides; 2007 Mar; 28(3):708-18. PubMed ID: 17109997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
